Preclinical therapeutic development demands a robust understanding of how a molecule behaves within the body. This involves evaluating its absorption, distribution, metabolism, and excretion (ADME) properties. Preclinical DMPK services offer essential data to maximize drug candidates during the early stages of development, ultimately expediting the